Back
ESC Premium Access

Do hypertensive women with coronary artery disease benefit from lowering systolic blood pressure under 130 mmHg? Long-term mortality in the INternational VErapamil SR-trandolapril STudy (INVEST)

Session: Hypertension: epidemiology, targets and comorbidities
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor R. Sava (Massy, FR)
Event: ESC Congress 2019

Congress Presentation

Add to my library

Like

About the speaker

Doctor Ruxandra Sava

Cardiovascular Institute Paris-Sud (ICPS), Massy (France)
0 follower

6 more presentations in this session

2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT

Speaker: Doctor M. Pareek (Copenhagen, DK)

Access
Abstract
Slides
Like
Thumbnail

All-cause mortality and cardiovascular death according to blood pressure thresholds recommended by ACC/AHA

Speaker: Doctor G. Joseph (Roskilde, DK)

Access
Abstract
Slides
Like
Thumbnail

Association of systolic blood pressure and cardiovascular outcomes at different age groups in the healthy general population: a nationwide prospective cohort study

Speaker: Doctor M. Jung (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Restricted mean survival time analysis to assess efficacy and safety of intensive vs standard blood pressure treatment goals as a function of age: insights from the SPRINT trial

Speaker: Doctor A. Krishnaswami (San Jose, US)

Access
Abstract
Slides
Like
Thumbnail

Optimal blood pressure in diabetic hypertensive patients with overt proteinuria

Speaker: Professor S. Park (Seoul, KR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Hypertension: epidemiology, targets and comorbidities

Speakers: Doctor R. Sava, Doctor M. Pareek, Doctor G. Joseph, Doctor M. Jung, Doctor A. Krishnaswami...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources